AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) --Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of A
